FDA Expands Pfizer Booster Use to 16-17 Years-Old
On 12/9/2021, the U.S. Food and Drug Administration (FDA) expanded the use of a single Pfizer-BioNTech COVID-19 Vaccine booster dose to individuals 16 and 17 years of age at least six months after completion of primary vaccination with the Pfizer …
FDA Expands Pfizer Booster Use to 16-17 Years-Old Read more »